16 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
reporting;
establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
recommending based upon … ,” if and when required, to be included in our annual proxy statement; and
reviewing and approving the retention or termination of any consulting firm
8-K
EX-1.1
PRME
Prime Medicine Inc
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
such reports and financial statements to the Representatives to the extent they are filed on EDGAR.
(m) Record Retention. The Company will, pursuant
DEF 14A
PRME
Prime Medicine Inc
28 Apr 23
Definitive proxy
8:34am
for the receipt and retention of accounting-related complaints and concerns;
recommending based upon the audit committee’s review and discussions … and Analysis,” if and when required, to be included in our annual proxy statement; and
reviewing and approving the retention or termination of any
S-1
EX-10.6
2e9cizve
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.7
2scx pdxdlietn7tps3
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.14
alw6l3im5
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.4
t6rmdg6n1v1bv6ddc
23 Sep 22
IPO registration
4:12pm
S-1
EX-1.1
xr8j4n3jsao8xu3t3
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.13
v4npcqdh9oxa
23 Sep 22
IPO registration
4:12pm
DRS/A
EX-10.6
g45j4b
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
63sg8ka42 t0ncnz8yre
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
b8ekbor1vvj5ljzbs
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
qr1fei9k16k0py azhob
12 Jan 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.13
4uk1cv3jphjet864q4kj
12 Jan 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next